Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Cited by (1,001)

Items 901–1,000 of 1,001

1. Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms
   Mark Tristan J. Quimque, Kin Israel Notarte, Von Novi de Leon, Joe Anthony Manzano, John Emmanuel R. Muñoz, Delfin Yñigo H. Pilapil, Justin Allen K. Lim, Allan Patrick G. Macabeo · 2022 · Springer eBooks
2. Infectivity of pseudotyped SARS‐CoV‐2 variants of concern in different human cell types and inhibitory effects of recombinant spike protein and entry‐related cellular factors
   George Fei Zhang, W. Meng, Lu-Ping Chen, Ling Ding, Shen-Yu Sun, Xian Wang, Yufei Huang, Hai-Tao Guo, Shou-Jiang Gao · 2022 · Journal of Medical Virology
3. Stable production of recombinant SARS-CoV-2 receptor-binding domain in mammalian cells with co-expression of a fluorescent reporter and its validation as antigenic target for COVID-19 serology testing
   Jorge L. Arias-Arias, Silvia Molina‐Castro, Laura Monturiol‐Gross, Bruno Lomonte, Eugenia Corrales‐Aguilar · 2022 · Biotechnology Reports
4. RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2
   Hernan Hermes Monteiro da Costa, Diego J. B. Orts, Andrew D. Moura, Amaro Nunes Duarte‐Neto, Cinthya dos Santos Cirqueira, Rodrigo Albergaria Réssio, Cristina Takami Kanamura, Karen Miguita, Jerenice Esdras Ferreira, Raimunda Telma de Macêdo Santos et al. · 2023 · Viruses
5. Deep Convolutional Neural Networks for Detecting COVID-19 Using Medical Images: A Survey
   Rana Khattab, Islam R. Abdelmaksoud, Samir Mohamed Abdelrazek · 2023 · New Generation Computing
6. ViPRA-Haplo: De Novo Reconstruction of Viral Populations Using Paired End Sequencing Data
   Weiling Li, Raunaq Malhotra, Steven Wu, Manjari Jha, Allen G. Rodrigo, Mary L. Poss, Raj S. Acharya · 2024 · IEEE Transactions on Computational Biology and Bioinformatics
7. Modelling and docking of Indian SARS-CoV-2 spike protein 1 with ACE2: implications for co-morbidity and therapeutic intervention
   Dhanashree D. Jagtap, Selvaa Kumar C, Smita D. Mahale, Vainav V. Patel · 2020 · arXiv (Cornell University)
8. Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization v1
   Bei Wang, Daniel E. Asarnow, Wen-Hsin Lee, Ching-Wen Huang, Bryan Faust, Patricia Miang Lon Ng, Eve Zi Xian Ngoh, Markus‐Frederik Bohn, David P. Bulkley, Andrés Pizzorno et al. · 2020
9. Bacterial expression and purification of functional recombinant SARS-CoV-2 spike receptor binding domain
   Janani Prahlad, Lucas R. Struble, William E. Lutz, Savanna A. Wallin, Surender Khurana, Andy T. Schnaubelt, Mara Jana Broadhurst, Kenneth W. Bayles, Gloria E.O. Borgstahl · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
10. Integrating Conformational Dynamics and Perturbation-Based Network Modeling for Mutational Profiling of Binding and Allostery in the SARS-CoV-2 Spike Variant Complexes with Antibodies: Balancing Local and Global Determinants of Mutational Escape Mechanisms
    Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan · 2022 · Biomolecules
11. Label-Free Analysis of Binding and Inhibition of SARS-Cov-19 Spike Proteins to ACE2 Receptor with ACE2-Derived Peptides by Surface Plasmon Resonance
    Fatimah Abouhajar, Rohit Chaudhuri, Santino N. Valiulis, Daniel D. Stuart, Alexander S. Malinick, Min Xue, Quan Jason Cheng · 2022 · ACS Applied Bio Materials
12. Like a summer storm: Biothermodynamic analysis of Rotavirus A - Empirical formula, biosynthesis reaction and driving force of virus multiplication and antigen-receptor binding
    Marko E. Popovic, Gavrilo M. Šekularac, Marija Mihailović · 2024 · Microbial Risk Analysis
13. AlphaFold2-Enabled Atomistic Modeling of Structure, Conformational Ensembles, and Binding Energetics of the SARS-CoV-2 Omicron BA.2.86 Spike Protein with ACE2 Host Receptor and Antibodies: Compensatory Functional Effects of Binding Hotspots in Modulating Mechanisms of Receptor Binding and Immune Escape
    Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, Sian Xiao, Peng Tao, Gennady M. Verkhivker · 2024 · Journal of Chemical Information and Modeling
14. Substance P – a regulatory peptide with defense and repair functions. Results and perspectives for the fight against COVID-19
    Riffat Mehboob, PETER OEHME, Tehreem Anwar, Jens Peter von Kries · 2024 · Frontiers in Neurology
15. Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
    Chunsheng Zhu, Bao Sun, Xiaochuan Zhang, Bing Zhang · 2020 · Frontiers in Pharmacology
16. Immunological aspects of coronavirus disease caused by SARS-CoV-2
    Абакушина Елена Вячеславовна · 2020 · Genes and Cells
17. SARS-CoV-2–host cell surface interactions and potential antiviral therapies
    Aura-Bianca Butnariu, Alex Look, Marta Grillo, Tanveer Ahmad Tabish, Michael J. McGarvey, Md Zahidul Islam Pranjol · 2021 · Interface Focus
18. Neurological Disorders Seen During Second Wave of SARS-CoV-2 Pandemic from Two Tertiary Care Centers in Central and Southern Kerala
    Minu George, Neena Baby, Ameen Azad, Aswathy Rajan, Sureshkumar Radhakrishnan · 2021 · Annals of Indian Academy of Neurology
19. Antigen–Antibody Complex-Guided Exploration of the Hotspots Conferring the Immune-Escaping Ability of the SARS-CoV-2 RBD
    Kit-Man Fung, S. Lai, Tzu-Lu Lin, T. Tseng · 2022 · Frontiers in Molecular Biosciences
20. Dietary guidelines to boost immunity during pre and post covid-19 conditions
    Mahwish, Farhan Saeed, Muhammad Afzaal, Muzzamal Hussain, Muhammad Imran, Taufiq Nawaz, Azhari Siddeeg · 2022 · International Journal of Food Properties
21. Antibody–nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants
    Hung Van Nguyen, Mai Suan Li · 2022 · Scientific Reports
22. On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
    Lorena O. Fernandes-Siqueira, Fabiana A. P. Ferreira, Bruna G. Sousa, Nathane Cunha Mebus-Antunes, Thais Cristtina Neves-Martins, Fábio C. L. Almeida, Gustavo C. Ferreira, Didier Salmon, Luciana Serrão Wermelinger, Andrea Thompson Da Poian · 2022 · Scientific Reports
23. A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS – CoV- 2 (COVID – 19)
    Ayushi Rastogi, Abhilasha Shiv Chandra Singh, Kaustubh Naik, Archana Mishra, Shilpi Chaudhary, Rajiv Manohar, Avanish Singh Parmar · 2022 · Journal of Molecular Liquids
24. Effect of Recombinant Antibodies and MIP Nanoparticles on the Electrical Behavior of Impedimetric Biorecognition Surfaces for SARS-CoV-2 Spike Glycoprotein: A Short Report
    Douglas Vieira Thomaz, Riccardo Goldoni, Gianluca Martino Tartaglia, Cosimino Malitesta, Elisabetta Mazzotta · 2022 · Electrochem
25. The Stability Study of Electrochemical Aptasensor to Detect SARS-CoV-2 Spike Protein and Its Application for Clinical Samples of Nasopharyngeal Swab
    Arum Kurnia Sari, Ghina Nur Fadhilah, Irkham Irkham, Muhammad Yusuf, Shabarni Gaffar, Yeni Wahyuni Hartati · 2023 · Indonesian Journal of Chemistry
26. Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface
    Kelly Bugatti, Andrea Sartori, Lucia Battistini, Crescenzo Coppa, Emiel Vanhulle, Sam Noppen, Becky Provinciael, Lieve M. J. Naesens, Annelies Stevaert, Alessandro Contini et al. · 2023 · International Journal of Molecular Sciences
27. Role of endothelial cells and angiotensin converting enzyme-II in COVID-19 and brain damages post-infection
    Riffat Mehboob, Jens Peter von Kries, Kashifa Ehsan, Majid Almansouri, Ahmed Khamis Bamaga · 2023 · Frontiers in Neurology
28. Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
    Gaurav Nagar, Siddharth Jain, Meghraj P. Rajurkar, Rakesh R. Lothe, Harish D. Rao, Sourav Majumdar, Manish Gautam, Sergio A. Rodriguez‐Aponte, Laura E. Crowell, John Christopher Love et al. · 2023 · Vaccines
29. Single-Molecule Analysis of SARS-CoV-2 Double-Stranded Polynucleotides Using Solid-State Nanopore with AI-Assisted Detection and Classification: Implications for Understanding Disease Severity
    Ibrar Alam, Thitikorn Boonkoom, Harit Pitakjakpipop, Poramin Boonbanjong, Kawin Loha, Thanaya Saeyang, Jarunee Vanichtanankul, Deanpen Japrung · 2024 · ACS Applied Bio Materials
30. Liver injury in COVID-19: two clinical cases
    Igor Gennadievich Nikitin, L. Yu. Ilchenko, И. Г. Федоров, Тотолян Гаяне Гургеновна · 2020 · Almanac of Clinical Medicine
31. Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors
    Jorge H. Rodriguez, Akshita Gupta · 2021 · Scientific Reports
32. COVID-19: insights into virus–receptor interactions
    Azadeh Sepahvandi, Maryam Selk Ghaffari, Amir Hossein Bahmanpour, Fathollah Moztarzadeh, Payam Zarrintaj, Hasan Uludağ, Masoud Mozafari · 2021 · Molecular Biomedicine
33. Emerging Trends of Bioinformatics in Health Informatics
    Mahi Sharma, Shuvhra Mondal, Sudeshna Bhattacharjee, Neetu Jabalia · 2021 · Health information science
34. Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases
    Aishwarya Mary Johnson, Robert Barigye, Hariharan Saminathan · 2021 · Human Vaccines & Immunotherapeutics
35. Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
    Enrique Ambrocio-Ortiz, Gloría Pérez-Rubio, Alma D. Del Ángel-Pablo, Ivette Buendía-Roldán, Leslie Chávez‐Galán, Rafael de Jesús Hernández-Zenteno, Alejandra Ramírez‐Venegas, Jorge Rojas‐Serrano, Mayra Edith Mejía, Rogelio Pérez‐Padilla et al. · 2021 · Pharmaceuticals
36. Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats
    Daniel J. Nesbitt, Daniel K. Jin, Joseph W. Hogan, Jenny Yang, Haidee Chen, Philip A. Chan, Melissa J. Simon, Matthew Vargas, Ewa King, Richard C. Huard et al. · 2021 · BMC Infectious Diseases
37. SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases
    Gonzalo Ferreira, Axel Santander, Florencia Savio, Mariana Guirado, Luis Sobrevía, Garth L. Nicolson · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
38. Secondary Structures of the Transmembrane Domain of SARS-CoV-2 Spike Protein in Detergent Micelles
    Qingxin Li, Qiwei Huang, CongBao Kang · 2022 · International Journal of Molecular Sciences
39. Unique Mode of Antiviral Action of a Marine Alkaloid against Ebola Virus and SARS-CoV-2
    Mai Izumida, Osamu Kotani, Hideki Hayashi, Chris E Smith, Tsutomu Fukuda, Koushirou Suga, Masatomo Iwao, Fumito Ishibashi, Hironori Sato, Yoshinao Kubo · 2022 · Viruses
40. Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies
    D. Beshnova, Yan Fang, Mingjian Du, Yehui Sun, Feng-He Du, Jianfeng Ye, Zhi-Jian J. Chen, Bo Li · 2022 · Computational and Structural Biotechnology Journal
41. Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models
    Ricardo Choque-Guevara, Astrid Poma-Acevedo, Ricardo Montesinos, Dora Ríos-Matos, Kristel Gutiérrez-Manchay, Ángela Montalván-Ávalos, Stefany Quiñones-García, Maria De Grecia Cauti Mendoza, Andrés Agurto-Arteaga, Ingrid Ramirez-Ortiz et al. · 2022 · PLoS ONE
42. A Putative long-range RNA-RNA interaction between ORF8 and Spike of SARS-CoV-2
    Okiemute Beatrice Omoru, Filipe Pereira, Sarath Chandra Janga, Amirhossein Manzourolajdad · 2022 · PLoS ONE
43. Integrating in silico and in vivo approach for investigating the role of polyherbal oil in prevention and treatment of COVID-19 infection
    Amul S Bahl, Vipin Kumar Verma, Jagriti Bhatia, Dharamvir Singh Arya · 2022 · Chemico-Biological Interactions
44. Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis
    Jiefeng Zhao, Jinfeng Zhu, Chao Huang, Xiaojian Zhu, Zhengming Zhu, Qinrong Wu, Rongfa Yuan · 2022 · Frontiers in Immunology
45. In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2
    Elena G. Geromichalou, George D. Geromichalos · 2022 · Molecules
46. Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma
    Ihn Han, Sohail Mumtaz, Sekar Ashokkumar, Dharmendra Kumar Yadav, Eun Ha Choi · 2022 · Current Issues in Molecular Biology
47. Repurposing immune boosting and anti-viral efficacy of Parkia bioactive entities as multi-target directed therapeutic approach for SARS-CoV-2: exploration of lead drugs by drug likeness, molecular docking and molecular dynamics simulation methods
    Roy Dinata, Nisekhoto Nisa, Chettri Arati, Borgohain Rasmita, Chetia Uditraj, Rajkonwar Siddhartha, Baishya Bhanushree, Laskar Saeed-Ahmed, Bose Manikandan, Rema Momin Bidanchi et al. · 2023 · Journal of Biomolecular Structure and Dynamics
48. A Systematic Literature Review of Current Therapeutic Approaches for COVID-19 Patients
    Saber Soltani, Amir Mohammad Zakeri, Mohammad Reza Karimi, Sara Akhavan Rezayat, Fatemeh Zomorodi Anbaji, Alireza Tabibzadeh, Parastoo Yousefi, Armin Zakeri, Ali Jafarpour, Mehdi Norouzi et al. · 2020 · Journal of Pharmaceutical Research International
49. Clinical characteristics and infectivity of asymptomatic carriers of SARS‑CoV‑2 (Review)
    Wanying Zhang, Xuejie Wu, Hui Zhou, Feng Xu · 2020 · Experimental and Therapeutic Medicine
50. COVID-19 and the Microbiome: The Gut-Lung Connection
    Femke J. Aan, Natalija Glibetić, Vanessa Montoya‐Uribe, Michelle L. Matter · 2021 · Elsevier eBooks
51. Combating the Progression of Novel Coronavirus SARS-CoV-2 Infectious Disease: Current State and Future Prospects in Molecular Diagnostics and Drug Discovery
    Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Sharad Thakur, Sanjay Kumar · 2021 · Current Molecular Medicine
52. The Use of Captopril—Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic
    Chandra Shekhar Biyani, Victor Palit, Sunil Daga · 2020 · Urology
53. RAAS blockade, kidney disease, and expression of ACE2 , the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells
    Ayshwarya Subramanian, Katherine A. Vernon, Michal Slyper, Julia Waldman, Malte D. Luecken, Kirk Gosik, Dan Dubinsky, Michael S. Cuoco, Keith H. Keller, Jason Purnell et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
54. A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19
    Daohong Zhang, Deepak Kukkar, Ki‐Hyun Kim, Poornima Bhatt · 2024 · International Journal of Biological Macromolecules
55. Exploring Binding Pockets in the Conformational States of the SARS-CoV-2 Spike Trimers for the Screening of Allosteric Inhibitors Using Molecular Simulations and Ensemble-Based Ligand Docking
    Grace Gupta, Gennady M. Verkhivker · 2024 · International Journal of Molecular Sciences
56. A review of COVID‐19 vaccines and major considerations for diabetic patients
    Saber Soltani, Milad Zandi, Parisa Shiri Aghbash, Masoud Rezaei, Nader Mohammadzadeh, Alireza Afsharifar, Vahdat Poortahmasebi · 2020 · Biotechnology and Applied Biochemistry
57. IDbSV: An Open-Access Repository for Monitoring SARS-CoV-2 Variations and Evolution
    Abdelmounim Essabbar, Souad Kartti, Tarek Alouane, Mohammed Hakmi, Lahcen Belyamani, Azeddine Ibrahimi · 2021 · Frontiers in Medicine
58. SARS-CoV-2 and extracellular vesicles: An intricate interplay in pathogenesis, diagnosis and treatment
    Caterina Sbarigia, Diana Vardanyan, Luca Buccini, Stefano Tacconi, Luciana Dini · 2022 · Frontiers in Nanotechnology
59. The Association between SARS-CoV-2 Infection and Diabetic Ketoacidosis in Patients with New-Onset Diabetes: A Retrospective Study from a Diabetic Center in Saudi Arabia
    Eman Hurissi, Mohammed Alameer, Fadiyah Ageeli, Maram Allami, Mohammed AlHarbi, Hussam M Suhail, Hadeel Albeishy, Omar Oraibi, Mohammed Somaili, Abdulrahman Ahmed Hummadi et al. · 2022 · Pediatric Reports
60. Riding the Wave: Unveiling the Conformational Waves from RBD of SARS-CoV-2 Spike Protein to ACE2
    Nikhil Maroli · 2023 · The Journal of Physical Chemistry B
61. Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients
    Xiaobo Huang, Jonas Kantonen, Kirsten Nowlan, Ngoc-anh A. Nguyen, Suvi Tuulia Jokiranta, Suvi H. Kuivanen, Nelli Heikkilä, Shamita Mahzabin, Anu Kantele, Olli P. Vapalahti et al. · 2024 · Virus Research
62. Identification of a broad-spectrum high-affinity peptide ligand for the purification of spike proteins
    Mengke Hu, Xiaoyan Dong, Qinghong Shi, Yan Ping Sun · 2024 · Journal of Chromatography A
63. Metabolomic Analysis and Antiviral Screening of a Marine Algae Library Yield Jobosic Acid (2,5-Dimethyltetradecanoic Acid) as a Selective Inhibitor of SARS-CoV-2
    Marie L. Matos‐Hernández, Robert M. Samples, Grayce E. Dyer, Victoria M. Casimir‐Montán, Chris A. Morales-Colón, Joseph M. Salvino, Luis J. Montaner, Joel A. Cassel, Troy E. Messick, Ian Tietjen et al. · 2024 · Journal of Natural Products
64. 2-heptanone and 2,3-butanediol from endophytic Bacillus subtilis GEB-1 against root-knot nematode, Meloidogyne enterolobii : a computational and experimental approach
    Ganeshan Shandeep, Shanthi Annaiyan, Jayakanthan Mannu, Prabhu Somasundaram, Angappan Kathithachalam, Haripriya Shanmugam, Settu Vijay · 2024 · Biocontrol Science and Technology
65. Antibody drugs targeting SARS-CoV-2: Time for a rethink?
    Likeng Liang, Bo Wang, Qing Zhang, Shiwu Zhang, Sihe Zhang · 2024 · Biomedicine & Pharmacotherapy
66. Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
    Devivasha Bordoloi, Ziyang Xu, Michelle Ho, Mansi Purwar, Pratik Sanjivkumar Bhojnagarwala, Joel A. Cassel, Leila B. Giron, Susanne N. Walker, Abhijeet J. Kulkarni, Edgar Tello‐Ruiz et al. · 2021 · ACS Pharmacology & Translational Science
67. Antisense Peptide Technology for Diagnostic Tests and Bioengineering Research
    Nikola Štambuk, Paško Konjevoda, Josip Pavan · 2021 · International Journal of Molecular Sciences
68. Immunomodulation and immunotherapeutics of COVID-19
    Sourbh Suren Garg, Atulika Sharma, Jeena Gupta · 2021 · Clinical Immunology
69. Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor
    Wantanee Treewattanawong, Thassanai Sitthiyotha, Surasak Chunsrivirot · 2021 · Scientific Reports
70. A Look inside the Replication Dynamics of SARS-CoV-2 in Blyth’s Horseshoe Bat ( Rhinolophus lepidus ) Kidney Cells
    Heidi Auerswald, Dolyce H. W. Low, Jurre Y. Siegers, Tey Putita Ou, Sonita Kol, Saraden In, Martin Linster, Yvonne C. F. Su, Ian Hewitt Mendenhall, Veasna Duong et al. · 2022 · Microbiology Spectrum
71. Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection
    Wernér E.G. Müller, Xiaohong Wang, Meik Neufurth, Heinz Christoph Schröder · 2022 · Progress in molecular and subcellular biology
72. Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern
    Ben Katowa, Annie Kalonda, Benjamin Mubemba, Japhet Matoba, Doreen Mainza Shempela, Jay Sikalima, Boniface Kabungo, Katendi Changula, Simbarashe Chitanga, Mpanga Kasonde et al. · 2022 · Viruses
73. Point mutation consideration in CcO protein of the electron transfer chain by MD simulation
    Mahnaz Shojapour, Somayeh Farahmand · 2022 · Journal of Molecular Graphics and Modelling
74. A comparative study of receptor interactions between SARS-CoV and SARS-CoV-2 from molecular modeling
    Hien T. T. Lai, Ly Nguyen, Anh Duc Phan, Agata Kranjc, Toan T. Nguyen, Duc Nguyen Manh · 2022 · Journal of Molecular Modeling
75. An Escherichia coli Expressed Multi-Disulfide Bonded SARS-CoV-2 RBD Shows Native-like Biophysical Properties and Elicits Neutralizing Antisera in a Mouse Model
    Subbaian Brindha, Takahiro Yoshizue, Rawiwan Wongnak, Hitoshi Takemae, Mami Oba, Tetsuya Mizutani, Yutaka Kuroda · 2022 · International Journal of Molecular Sciences
76. A bioengineered pseudovirus nanoparticle displaying SARS‐CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS‐CoV 2 challenge
    Ming Xia, Krisangel López, Frank S. Vago, Pengwei Huang, Dawn I. Auguste, Wen Jiang, Albert J. Auguste, Ming Tan · 2023 · Biotechnology Journal
77. Effects of spike proteins on angiotensin converting enzyme 2 (ACE2)
    Jennyfer Bejoy, Charlye I. Williams, Hattie J. Cole, Shavaiz Manzoor, Parsa Davoodi, Jacqueline I. Battaile, Arjun Kaushik, Sofia I. Nikolaienko, Tinatin I. Brelidze, Sergiy G. Gychka et al. · 2023 · Archives of Biochemistry and Biophysics
78. High‐dose vitamin D supplementation in patients with COVID ‐19: A meta‐analysis of randomized controlled trials
    Zhaoshuang Zhong, Long Zhao, Yan Zhao, Shuyue Xia · 2023 · Food Science & Nutrition
79. Evaluation of Photobiogoverning Role of Blue Light Irradiation on Viral Replication
    Phil‐Sun Oh, Kyung Won Kang, Seung Rok Ryu, Seok Tae Lim, Myung‐Hee Sohn, Sang‐Myeong Lee, Hwan‐Jeong Jeong · 2021 · Photochemistry and Photobiology
80. Elucidating the differences in the molecular mechanism of receptor binding between 2019-nCoV and the SARS-CoV viruses using computational tools
    Hien T. T. Lai, Ly Hai Nguyen, Agata Kranjc, Toan T. Nguyen, Duc Nguyen Manh · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
81. The discovery of potential natural products for targeting SARS-CoV-2 spike protein by virtual screening
    Guanyu Chen, Tsung-You Yao, Azaj Ahmed, Yi‐Cheng Pan, Juan‐Cheng Yang, Yang‐Chang Wu · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
82. The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity
    Emily Shang, P. Axelsen · 2020 · bioRxiv
83. Molecular Docking study of Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein with Saikosaponin, a Triterpenoid Natural Product
    Tamal Goswami, Bhaskar Bagchi · 2020 · ChemRxiv
84. Efficient Purification of Polyhistidine-Tagged Recombinant Proteins Using Functionalized Corundum Particles
    Jule L. Völzke, Sarah Smatty, Sarah Döring, Shireen Ewald, Marcus Oelze, Franziska Fratzke, Sabine Flemig, Zoltán Konthur, Michael G. Weller · 2023 · BioTech
85. Host-Directed Virus-Mimicking Particles Interacting with the ACE2 Receptor Competitively Block Coronavirus SARS-CoV-2 Entry
    Pei Zhang, Erik Niemelä, Sandra López Cérda, Pasi Sorvisto, Jani Virtanen, Hélder A. Santos · 2024 · Nano Letters
86. Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
    D. N. Kisakov, Л. И. Карпенко, L. A. Kisakova, Sergey V. Sharabrin, Mariya Borisovna Borgoyakova, Ekaterina V. Starostina, Oleg Svyatoslavovich Taranov, Elena K. Ivleva, Oleg V. Pyankov, Anna V. Zaykovskaya et al. · 2025 · Vaccines
87. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
    Cameron Grant McCarthy, Piu Saha, Rachel M. Golonka, Camilla Ferreira Wenceslau, Bina Joe, Matam Vijay–Kumar · 2021 · Comprehensive physiology
88. Investigating DNA Aptamer Binding to Domains of the SARS‐CoV‐2 Spike Protein: Insights from Molecular Dynamics and MM/PBSA Analysis
    Sarah Bartley, Kristen L. Rhinehardt, Kristen Dellinger · 2025 · ChemistrySelect
89. The Integration of Nanotechnology, Artificial Intelligence (AI), Machine Learning (ML) and 3D-Bioprinting Approaches for Personalized COVID-19 Treatment
    Md Jasim Uddin, A. Gholap, Tahseen Khan, Amrin Yeasin Proma, Sinthia Masud, Y. Choonara, S. Gowri, Thomas J. Webster, M. Faiyazuddin · 2024 · Journal of Biomedical Nanotechnology
90. Integrative Computational Modeling of Distinct Binding Mechanisms for Broadly Neutralizing Antibodies Targeting SARS-CoV-2 Spike Omicron Variants: Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune Escape
    Mohammed Alshahrani, Vedant Parikh, Brandon Foley, Gennady M. Verkhivker · 2025 · Viruses
91. Ultrasensitive electrochemical biosensor using Carboxylated graphitic carbon nitride-nanogold composite for SARS-CoV-2 receptor binding protein
    P.R. Ramya, Shivmuni Sarup, Ivan Jerman, Raghuraj Singh Chouhan, Sonu Gandhi · 2025 · Microchemical Journal
92. SARS-CoV-2 vaccines: current trends and prospects of developing plant-derived vaccines
    Balamurugan Shanmugaraj, Narach Khorattanakulchai, Waranyoo Phoolcharoen · 2021 · Elsevier eBooks
93. Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID‐19 cohorts by chemiluminescent immunoassays
    X. Dou, E. Wang, Ruiwei Jiang, Min Li, D. Xiong, Bao-Qing Sun, Xiu-Ming Zhang · 2022 · Immunity, Inflammation and Disease
94. Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern
    Erika Rudi, Pablo Martín Aispuro, Eugenia Zurita, María Mora González López Ledesma, Daniela Bottero, Juan Pablo Malito, Magalí Gabrielli, María Emilia Gaillard, Matthew Stuible, Yves Durocher et al. · 2022 · Frontiers in Immunology
95. 2,4-Dihydroxycinnamic acid as spike ACE2 inhibitor and apigenin as RdRp inhibitor in Nimbamritadi Panchatiktam Kashayam against COVID-19: an in silico and in vitro approach
    Maneesha Murali, Bhagyalakshmi Nair, V.R. Vishnu, T P Aneesh, Lekshmi R. Nath · 2022 · Molecular Diversity
96. Ethnopharmacological Potential of Phytochemicals and Phytogenic Products against Human RNA Viral Diseases as Preventive Therapeutics
    Anamika Paul, Nilanjan Chakraborty, Anik Sarkar, Krishnendu Acharya, Anuj Ranjan, Abhishek Pratap Singh Chauhan, Shilpi Srivastava, Akhilesh Kumar Singh, Ashutosh Kumar, Iqra Mubeen et al. · 2023 · BioMed Research International
97. In-silico approach to designing effective antiviral drugs against SARS-CoV-2 and SARS-CoV-1 from reported phytochemicals: a quality improvement study
    Fatema- Tuz-Zohura, Abu Rashed Md. Shawon, Md. Maruf Hasan, Abdullah Aeyas, Faisal Islam Chowdhury, Mayeen Uddin Khandaker · 2023 · Annals of Medicine and Surgery
98. Rapid development and mass production of SARS-CoV-2 neutralizing chicken egg yolk antibodies with protective efficacy in hamsters
    Binan Zhao, Haoran Peng, Yanjing Zhang, Jie Zhang, Desheng Kong, Sai Cao, Yan Li, Dan Yang, Chuanwen Sun, Xinyi Pu et al. · 2024 · Biological Research
99. COVID-19 FARMAKOTERAPİSİ
    Begüm Yurdakök-Di̇kmen, Yağız Pat, Ergin Dileköz, Gökçe Yağmur Summak, Oğuz Kul, Ayhan Filazı · 2020 · Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni
100. Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase
     Esen Sokullu, Maxime Pinard, Marie‐Soleil Gauthier, Benoit Coulombe · 2021 · Expert Opinion on Drug Discovery